Which findings typically cause an individual with idiopathic pulmonary fibrosis (IPF) to first seek medical care?

A) Peripheral edema and dyspnea on exertion
B) Shallow and fast respirations
C) Cyanosis and clubbing of fingernails
D) Dyspnea on exertion and cough with minimal sputum production


D) Dyspnea on exertion and cough with minimal sputum production

Explanation: A) IPF has an insidious onset that begins with dyspnea on exertion (DOE) and/or a cough that produces very little sputum. Disease progression may occur in a steplike process, with periods of relative stability, then marked worsening of the disease with an acute exacerbation. Deterioration of lung function can occur secondary to an infection, pulmonary embolism, pneumothorax, or heart failure. Even at rest, individuals with IPF have rapid, shallow respirations to limit the work of ventilating stiff lungs. Bibasilar inspiratory crackles and clubbing of the distal fingers are commonly present. Disease progression or acute exacerbation may cause increasing DOE, hypoxemia, and cyanosis. Heart failure and peripheral edema also may occur.

Nursing

You might also like to view...

Which of the following assessment findings is most specific for acute onset of pulmonary edema?

a. Pulmonary crackles c. Pink, frothy sputum b. Peripheral edema d. Elevated central venous pressure

Nursing

Nurses in change-of-shift report are discussing the care of a patient with a stroke who has progressively increasing weakness and decreasing level of consciousness (LOC). Which nursing diagnosis do they determine has the highest priority for the patient?

a. Impaired physical mobility related to weakness b. Disturbed sensory perception related to brain injury c. Risk for impaired skin integrity related to immobility d. Risk for aspiration related to inability to protect airway

Nursing

The application of drugs for the purpose of disease prevention and treatment of suffering is known as

1. biologics. 2. pharmacotherapeutics. 3. alternative therapies. 4. therapeutics.

Nursing

A patient administers interferon beta-1a SQ (Rebif) 22 mcg/0.5 mL three times each week

The patient calls the nurse to report unrelieved itching and erythema at the injection site, despite the use of topical hydrocortisone for several weeks. What will the nurse tell this patient to do? a. Apply ice to the injection site before and after the injection. b. Ask the provider to reduce the dose of interferon beta to 8.8 mcg/0.2 mL. c. Discuss using a prescription-strength hydrocortisone product with the provider. d. Take oral diphenhydramine (Benadryl).

Nursing